Business

July 16, 2014 11:02 AM

Pozen resubmits new drug application

Chapel Hill drugmaker Pozen announced Wednesday that federal regulators have accepted the resubmission of its new drug application for its heart attack and stroke-prevention pill.

Related content

Comments